<DOC>
	<DOCNO>NCT01682876</DOCNO>
	<brief_summary>This study design conduct comparative trial evaluate safety , immunogenicity antibody persistence two dos Novartis MenACWY conjugate vaccine , give 2 month apart , versus one dose Novartis MenACWY conjugate vaccine child 2 10 year age .</brief_summary>
	<brief_title>Immunogenicity , Safety 1 Year Persistence Antibodies After Either One Two Doses Meningococcal ACWY Conjugate Vaccine Healthy Children 2 Through 10 Years Age .</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Healthy child , 2 10 year age date routine childhood vaccination , accord U.S. ACIP recommendation 1 . Unwilling unable give write informed assent consent participate study . 2 . Perceived unreliable unavailable duration study period . 3 . Previous confirm suspected disease cause N. meningitidis . 4 . Previously immunized meningococcal vaccine ( licensed investigational ) . 5 . Receipt investigational nonregistered product within 30 day prior enrolment expect receive investigational drug vaccine prior completion study . 6 . Receipt plan receive vaccine within 30 day administration dose study vaccine . ( certain exception influenza vaccine apply ) 7 . Significant acute infection within 7 day prior enrolment body temperature 38Â°C great within 3 day prior enrolment . 8 . Previous serious acute , chronic progressive disease , epilepsy progressive neurological disease history GuillainBarre syndrome . 9 . History anaphylaxis , serious vaccine reaction , allergy vaccine component 10 . Impairment/alteration immune function , either congenital acquire result ( example ) : receipt immunosuppressive therapy , receipt immunostimulants , receipt parenteral immunoglobulin preparation , blood product , and/or plasma derivative . 11 . Known bleed diathesis , condition may associate prolonged bleeding time .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Prevention meningococcal disease , child , vaccine</keyword>
</DOC>